---
title: "688278.SH (688278.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688278.SH/news.md"
symbol: "688278.SH"
name: "688278.SH"
parent: "https://longbridge.com/en/quote/688278.SH.md"
datetime: "2026-05-20T14:46:11.179Z"
locales:
  - [en](https://longbridge.com/en/quote/688278.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688278.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688278.SH/news.md)
---

# 688278.SH (688278.SH) — Related News

### [Pre-market announcement highlights: SMIC's 40.6 billion acquisition approved, Beijing-Shanghai High Speed Railway announces a 20% fare increase for some trains, and well-known investor Tu Wenbin "raises stake" in KHtech](https://longbridge.com/en/news/286013253.md)
*2026-05-12T00:37:20.000Z*
> SMIC's acquisition of 40.6 billion has been approved, with an issuance price of 74.2 yuan per share. The ticket prices f

### [Overview of A-share Stock Buybacks: 25 Companies Disclose Buyback Progress](https://longbridge.com/en/news/286008736.md)
*2026-05-11T23:39:10.000Z*
> On May 12th, 25 companies announced 26 stock repurchase updates, among which 11 companies disclosed their repurchase pla

### [Star Market Evening News | SMIC's 40.6 billion acquisition approved, MicroNano Star's Star Market IPO accepted](https://longbridge.com/en/news/285949530.md)
*2026-05-11T13:12:18.000Z*
> Today's Sci-Tech Innovation Board evening report includes: SMIC's acquisition of 40.6 billion approved, NANYA NEW MATERI

### [AMOYTOP: Plans to repurchase shares for 300 million to 500 million yuan](https://longbridge.com/en/news/285932649.md)
*2026-05-11T11:26:16.000Z*
> AMOYTOP announced that the company plans to repurchase shares through centralized bidding, with the repurchase amount no

### [AMOYTOP: Has completed a share repurchase of 199 million yuan, accounting for 0.84% of the total share capital](https://longbridge.com/en/news/285710221.md)
*2026-05-08T10:54:07.000Z*
> AMOYTOP announced that the company has completed a share repurchase of 199 million yuan, repurchasing 3.4396 million sha

### [AMOYTOP: Net profit in the first quarter of 2026 was 164 million yuan, a year-on-year decrease of 9.68%](https://longbridge.com/en/news/284347524.md)
*2026-04-28T09:56:46.000Z*
> AMOYTOP announced that its operating revenue for the first quarter of 2026 was 798 million yuan, a year-on-year increase

### [THDB released its 2025 annual performance, with a net profit attributable to the parent company of 1.219 billion yuan, turning a profit from a loss year-on-year](https://longbridge.com/en/news/283247044.md)
*2026-04-19T08:42:05.000Z*
> THDB released its 2025 annual report, with revenue of 2.947 billion yuan, a year-on-year increase of 46.66%; net profit 

### [AMOYTOP signs exclusive intellectual property cooperation agreement with Aligos](https://longbridge.com/en/news/282994317.md)
*2026-04-16T11:48:48.000Z*
> AMOYTOP has signed an exclusive intellectual property licensing agreement with Aligos Therapeutics in the United States,

### [AMOYTOP's performance meeting: Advancing clinical trials for new indications of core products such as Paigebin and Yipeisheng](https://longbridge.com/en/news/282511332.md)
*2026-04-13T08:44:23.000Z*
> On April 13th, AMOYTOP (688278) held a performance briefing. The company is an innovative biopharmaceutical enterprise f

### [In the second half of last year, China Europe Fund's Gran increased its holdings in JOINN and established a position in AMOYTOP, purchasing its own managed pharmaceutical fund](https://longbridge.com/en/news/281267084.md)
*2026-03-31T23:30:30.000Z*
> Zhongou Fund's investment director, Ge Lan, disclosed the holdings of three public funds in the 2025 annual report, show